Gross Profit On Sales Changement Date
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
Adcock Ingram Holdings ZAR 1.55B 93.45M 2023-06
Agios Pharmaceuticals USD 6.52M 249K 2023-12
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
Amgen USD 5.08B 14M 2023-12
Biogen USD 1.77B 102.7M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Bluebird Bio USD 1.44M 4.11M 2023-09
Deva Holding AS TRY 1.32B 235.77M 2023-09
Esperion Therapeutics USD 20.59M 1.59M 2023-09
Gilead Sciences USD 5.5B 18M 2023-12
GlaxoSmithKline GBP 5.91B 626M 2023-09
Incyte USD 949.29M 84.66M 2023-12
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
Knight Therapeutics CAD 40.18M 2.69M 2023-09
Laboratorios Farma EUR 217.46M 75.84M 2023-06
Malin Corporation EUR 3.8M 2.6M 2020-12
Moderna USD 1.88B 2.29B 2023-12
Organigram Holdings CAD -13092000 8.77M 2023-03
Pharma Mar EUR 34.31M 10.01M 2023-09
Qiagen NV USD 297.96M 14.19M 2023-09
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Sartorius EUR 359.9M 47M 2023-09
Sino Biopharmaceutical CNY 12.02B 1.27B 2023-06
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
United Therapeutics USD 543.7M 4.4M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09
Zz Pientze Pharmaceu 1.28B 201.8M 2023-09



Moderna La Marge Brute Sur Les Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.